171 related articles for article (PubMed ID: 28970170)
1. Microbial serine protease inhibitors and their therapeutic applications.
Harish BS; Uppuluri KB
Int J Biol Macromol; 2018 Feb; 107(Pt B):1373-1387. PubMed ID: 28970170
[TBL] [Abstract][Full Text] [Related]
2. A critical review on marine serine protease and its inhibitors: A new wave of drugs?
Barzkar N; Khan Z; Tamadoni Jahromi S; Pourmozaffar S; Gozari M; Nahavandi R
Int J Biol Macromol; 2021 Feb; 170():674-687. PubMed ID: 33387547
[TBL] [Abstract][Full Text] [Related]
3. Understanding serine proteases implications on Leishmania spp lifecycle.
Alves CR; Souza RS; Charret KDS; Côrtes LMC; Sá-Silva MP; Barral-Veloso L; Oliveira LFG; da Silva FS
Exp Parasitol; 2018 Jan; 184():67-81. PubMed ID: 29175018
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the serine proteases of the complement system.
Gál P; Dobó J; Beinrohr L; Pál G; Závodszky P
Adv Exp Med Biol; 2013; 735():23-40. PubMed ID: 23402017
[TBL] [Abstract][Full Text] [Related]
5. Viral serine protease inhibitors as anti-atherosclerotic therapy.
Bot I; van Berkel TJ; Biessen EA
Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406
[TBL] [Abstract][Full Text] [Related]
7. The Lord of the Bacteria: The Fellowship of the Leader and Other Serine Protease Inhibitors.
Burchacka E; Sieńczyk M
Curr Pharm Des; 2018; 24(37):4445-4465. PubMed ID: 30569850
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of serine protease inhibitor 1 from kuruma shrimp Marsupenaeus japonicus.
Zhao YR; Xu YH; Jiang HS; Xu S; Zhao XF; Wang JX
Dev Comp Immunol; 2014 Jun; 44(2):261-9. PubMed ID: 24412215
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in fungal serine protease inhibitors.
Burchacka E; Pięta P; Łupicka-Słowik A
Biomed Pharmacother; 2022 Feb; 146():112523. PubMed ID: 34902742
[TBL] [Abstract][Full Text] [Related]
10. Targeting serine proteases in asthma.
Guay C; Laviolette M; Tremblay GM
Curr Top Med Chem; 2006; 6(4):393-402. PubMed ID: 16611150
[TBL] [Abstract][Full Text] [Related]
11. [Advances of Kunitz-type serine protease inhibitors].
Liu Y; Jiang S; Li Q; Kong Y
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3988-4000. PubMed ID: 34841799
[TBL] [Abstract][Full Text] [Related]
12. Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass.
Royston D
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S42-9. PubMed ID: 8938283
[TBL] [Abstract][Full Text] [Related]
13. Small Peptides as Modulators of Serine Proteases.
Xu P; Huang M
Curr Med Chem; 2020; 27(22):3686-3705. PubMed ID: 30332941
[TBL] [Abstract][Full Text] [Related]
14. Microbial inhibitors of cysteine proteases.
Kędzior M; Seredyński R; Gutowicz J
Med Microbiol Immunol; 2016 Aug; 205(4):275-96. PubMed ID: 27048482
[TBL] [Abstract][Full Text] [Related]
15. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases.
El Amri C
Adv Exp Med Biol; 2021; 1304():215-226. PubMed ID: 34019272
[TBL] [Abstract][Full Text] [Related]
16. The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors.
Hudig D; Allison NJ; Pickett TM; Winkler U; Kam CM; Powers JC
J Immunol; 1991 Aug; 147(4):1360-8. PubMed ID: 1869829
[TBL] [Abstract][Full Text] [Related]
17. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
Van der Gucht W; Leemans A; De Schryver M; Heykers A; Caljon G; Maes L; Cos P; Delputte PL
Virol J; 2017 Aug; 14(1):157. PubMed ID: 28818113
[TBL] [Abstract][Full Text] [Related]
19. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
Konaklieva MI; Plotkin BJ
Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
[TBL] [Abstract][Full Text] [Related]
20. [Advances in researches on epididymal WFDC-type serine protease inhibitors].
Liu J; Wang HY; Li JY
Zhonghua Nan Ke Xue; 2008 Nov; 14(11):1027-30. PubMed ID: 19102507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
